CYP3A4-IN-6
CYP3A4-IN-6 (Compound 8a) is a CYP3A4 inhibitor with tissue-selective metabolism. CYP3A4-IN-6 remains stable in the intestinal S9 component but is rapidly metabolized in the liver S9 component, forming a less active metabolite. CYP3A4-IN-6 can be used for intestinal selectivity studies[1].
Product Specifications
UNSPSC
12352005
Target
Cytochrome P450
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Smiles
O=C(C1=CC=C(C=C1)COCC2=CC=C(C=C2)N3C=CN=C3)OC
Molecular Formula
C19H18N2O3
Molecular Weight
322.36
References & Citations
[1]Elsayed DA, et al. Antiplatelet therapy through inhibition of P2Y12 and phosphodiesterase receptors by novel synthesis 1,3-dicyclohexylpyrimidine-2,4 (1H,3H) -dione derivatives with computational evaluation. Bioorg Chem. 2025 Oct;165:109009.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP327709 20 µg
JMJD5 (KDM8) (NM_001145348) Human Recombinant Protein
Sign In for Pricing
View Details 
